New drug aims to curb relentless hunger in rare genetic disorder
Symptom relief
Recruiting now
This early-stage trial tests an experimental drug called CSTI-500 in 12 people with Prader-Willi syndrome, a genetic condition that causes constant, extreme hunger. The study aims to see if the drug is safe and can reduce the urge to overeat. Participants aged 13 to 50 will recei…
Phase: PHASE2 • Sponsor: ConSynance Therapeutics • Aim: Symptom relief
Last updated May 18, 2026 12:00 UTC